Nanomedicine for respiratory diseases

European Journal of Pharmacology

Volumn 533, Issue 1-3, 2006, Pages 341-350

  Pison, Ulrich ^a   Welte, Tobias ^b   Giersig, Michael ^c   Groneberg, David A ^a,b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c CENTER OF ADVANCED EUROPEAN STUDIES AND RESEARCH CAESAR   (Germany)

Author keywords

Nanocarrier; Nanomaterial; Nanoparticle; Nanotechnology; Quantum dot; Respiratory medicine

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; ALBUMIN; CALCIUM; CHLOROQUINE; DRUG CARRIER; ISONIAZID; MACROGOL; POLY(METHYL METHACRYLATE); POLYGLACTIN; POLYMER; PYRAZINAMIDE; RIFAMPICIN; SELECTIN ANTAGONIST; SOLID LIPID NANOPARTICLE; TETANUS TOXOID;

CANCER THERAPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL RESEARCH; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEM; DRUG ELIMINATION; DRUG HALF LIFE; DRUG TRANSPORT; HUMAN; LUNG TUBERCULOSIS; METERED DOSE INHALER; MOLECULAR IMAGING; NANOPARTICLE; NANOTECHNOLOGY; NONHUMAN; PRIORITY JOURNAL; REGENERATIVE MEDICINE; RESPIRATORY TRACT DISEASE; REVIEW; TARGET CELL; VACCINATION;

ANIMALS; CYSTIC FIBROSIS; DRUG DELIVERY SYSTEMS; GENE THERAPY; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; NANOMEDICINE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGENERATIVE MEDICINE; RESPIRATORY SYSTEM AGENTS; RESPIRATORY TRACT DISEASES; TUBERCULOSIS, PULMONARY;

EID: 33644752699     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.12.068     Document Type: Review

References (51)

1. M.E. Akerman, W.C. Chan, P. Laakkonen, S.N. Bhatia, and E. Ruoslahti Nanocrystal targeting in vivo Proc. Natl. Acad. Sci. USA. 99 2002 12617 12621
2. P. Aldhous Regenerative medicine - a world of difference Nature 414 2001 838
3. T.F. Boat, and P.W. Cheng Biochemistry of airway mucus secretions Fed. Proc. 39 1980 3067 3074
4. F. Bressolle, J.E. de la Coussaye, R. Ayoub, D. Fabre, R. Gomeni, G. Saissi, J.J. Eledjam, and M. Galtier Endotracheal and aerosol administrations of ceftazidime in patients with nosocomial pneumonia: pharmacokinetics and absolute bioavailability Antimicrob. Agents Chemother. 36 1992 1404 1411
5. K.V. Chace, M. Flux, and G.P. Sachdev Comparison of physicochemical properties of purified mucus glycoproteins isolated from respiratory secretions of cystic fibrosis and asthmatic patients Biochem. 24 1985 7334 7341
6. K.F. Chung, G. Caramori, and D.A. Groneberg Airway obstruction in chronic obstructive pulmonary disease N. Engl. J. Med. 351 2004 1459 1461
7. M.A. Correa-Duarte, N. Wagner, J. Rojas-Chapana, C. Morsczeck, M. Thie, and M. Giersig Fabrication and biocompatibility of carbon nanotube-based 3D networks as scaffolds for cell seeding and growth Nano Lett. 4 2004 2233 2236
8. J. Czernin, and M.E. Phelps Positron emission tomography scanning: current and future applications Annu. Rev. Med. 53 2002 89 112
9. J.R. Davies, H.W. Hovenberg, C.J. Linden, R. Howard, P.S. Richardson, J.K. Sheehan, and I. Carlstedt Mucins in airway secretions from healthy and chronic bronchitic subjects Biochem. J. 313 1996 431 439
10. P.A. Dayton, and K.W. Ferrara Targeted imaging using ultrasound J. Magn. Reson. Imaging 16 2002 362 377
11. J.F. Engelhardt, J.R. Yankaskas, S.A. Ernst, Y. Yang, C.R. Marino, R.C. Boucher, J.A. Con, and J.M. Wilson Submucosal glands are the predominant site of CFTR expression in the human bronchus Nat. Genet. 2 1993 240 248
12. S.S. Gambhir Molecular imaging of cancer with positron emission tomography Nat. Rev., Cancer 2 2002 683 693
13. B. Gopalan, I. Ito, C.D. Branch, C. Stephens, J.A. Roth, and R. Ramesh Nanoparticle based systemic gene therapy for lung cancer: molecular mechanisms and strategies to suppress nanoparticle-mediated inflammatory response Technol. Cancer Res. Treat. 3 2004 647 657
14. D.A. Groneberg, P.R. Eynott, S. Lim, T. Oates, R. Wu, I. Carlstedt, P. Roberts, B. McCann, A.G. Nicholson, B.D. Harrison, and K.F. Chung Expression of respiratory mucins in fatal status asthmaticus and mild asthma Histopathology 40 2002 367 373
15. D.A. Groneberg, C. Peiser, Q.T. Dinh, J. Matthias, P.R. Eynott, W. Heppt, I. Carlstedt, C. Witt, A. Fischer, and K.F. Chung Distribution of respiratory mucin proteins in human nasal mucosa Laryngoscope 113 2003 520 524
16. R. Gupta, and N. Jentoft The structure of tracheobronchial mucins from cystic fibrosis and control patients J. Biol. Chem. 267 1992 3160 3167
17. M.E. Hodson, A.R. Penketh, and J.C. Batten Aerosol carbenicillin and gentamicin treatment of Pseudomonas aeruginosa infection in patients with cystic fibrosis Lancet 2 1981 1137 1139
18. D. Hogemann, and J.P. Basilion "Seeing inside the body": MR imaging of gene expression Eur. J. Nucl. Med. Mol. Imaging 29 2002 400 408
19. D. Honeybourne Antibiotic penetration into lung tissues [editorial] Thorax 49 1994 104 106
20. A.E. John, N.W. Lukacs, A.A. Berlin, A. Palecanda, R.F. Bargatze, L.M. Stoolman, and J.O. Nagy Discovery of a potent nanoparticle P-selectin antagonist with anti-inflammatory effects in allergic airway disease FASEB J. 17 2003 2296 2298
21. E.E. Kim Targeted molecular imaging Korean J. Radiol. 4 2003 201 210
22. C. Koch, and N. Hoiby Pathogenesis of cystic fibrosis Lancet 341 1993 1065 1069
23. M. Kumar, A.K. Behera, R.F. Lockey, J. Zhang, G. Bhullar, C.P. De La Cruz, L.C. Chen, K.W. Leong, S.K. Huang, and S.S. Mohapatra Intranasal gene transfer by chitosan-DNA nanospheres protects BALB/c mice against acute respiratory syncytial virus infection Hum. Gene Ther. 13 2002 1415 1425
24. M. Kumar, X. Kong, A.K. Behera, G.R. Hellermann, R.F. Lockey, and S.S. Mohapatra Chitosan IFN-gamma-pDNA nanoparticle (CIN) therapy for allergic asthma Genet. Vaccines Ther. 1 2003 3
25. D.A. LaVan, D.M. Lynn, and R. Langer Moving smaller in drug discovery and delivery Nat. Rev. Drug Discov. 1 2002 77 84
26. D. Li, D. Wang, S. Mjumdar, B. Jany, S.R. Durham, J. Cottrell, N. Caplen, D.M. Geddes, E.W.F.W. Alton, and P.K. Jeffrey Localization and up-regulation of mucin (MUC2) gene expression in human nasal biopsies of patients with cystic fibrosis J. Pathol. 181 1997 305 310
27. U. Mahmood, and L. Josephson Molecular MR imaging probes Proc. IEEE 93 2005 800 808
28. S.M. Moghimi, A.C. Hunter, and J.C. Murray Nanomedicine: current status and future prospects FASEB J. 19 2005 311 330
29. K. Nakashima, S. Colamarino, and F.H. Gage Embryonic stem cells: staying plastic on plastic Nat. Med. 10 2004 23 24
30. G. Nolan, P. Moivor, H. Levison, P.C. Fleming, M. Corey, and R. Gold Antibiotic prophylaxis in cystic fibrosis: inhaled cephaloridine as an adjunct to oral cloxacillin J. Pediatr. 101 1982 626 630
31. R. Pandey, A. Sharma, A. Zahoor, S. Sharma, G.K. Khuller, and B. Prasad Poly (dl-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis J. Antimicrob. Chemother. 52 2003 981 986
32. S. Petit-Zeman Regenerative medicine Nat. Biotechnol. 19 2001 201 206
33. J. Pomerantz, and H.M. Blau Nuclear reprogramming: a key to stem cell function in regenerative medicine Nat. Cell Biol. 6 2004 810 816
34. B.W. Ramsey Management of pulmonary disease in patients with cystic fibrosis N. Engl. J. Med. 335 1996 179 188
35. T. Reya, S.J. Morrison, M.F. Clarke, and I.L. Weissman Stem cells, cancer, and cancer stem cells Nature 414 2001 105 111
36. B.J. Rosenstein, and P.L. Zeitlin Cystic fibrosis Lancet 351 1998 277 282
37. P. Roussel, G. Lamblin, and P. Degand Heterogeneity of the carbohydrate chains of sulfated bronchial glycoproteins isolated from a patient suffering from cystic fibrosis J. Biol. Chem. 250 1975 2114 2122
38. M. Rudin, and R. Weissleder Molecular imaging in drug discovery and development Nat. Rev. Drug Discov. 2 2003 123 131
39. P. Sharma, L. Dudus, P.A. Nielsen, H. Clausen, J.R. Yankaskas, M.A. Hollingsworth, and J.F. Engelhardt MUC5B and MUC7 are differentially expressed in mucous and serous cells of submucosal glands in human bronchial airways Am. J. Respir. Cell Mol. Biol. 19 1998 30 37
40. M.J. Shephard, D. Todd, B.M. Adair, A.L. Po, D.P. Mackie, and E.M. Scott Immunogenicity of bovine parainfluenza type 3 virus proteins encapsulated in nanoparticle vaccines, following intranasal administration to mice Res. Vet. Sci. 74 2003 187 190
41. M. Singer, L.D. Martin, B.B. Vargaftig, J. Park, A.D. Gruber, Y. Li, and K.B. Adler A MARCKS-related peptide blocks mucus hypersecretion in a mouse model of asthma Nat. Med. 10 2004 193 196
42. R.C. Stern The diagnosis of cystic fibrosis N. Engl. J. Med. 336 1997 487 491
43. D.J. Thornton, J.R. Davies, M. Kraayenbrink, P.S. Richardson, J.K. Sheehan, and I. Carlstedt Mucus glycoproteins from 'normal' human tracheobronchial secretion Biochem. J. 265 1990 179 186
44. D.J. Thornton, J.K. Sheehan, H. Lindgren, and I. Carlstedt Mucus glycoproteins from cystic fibrotic sputum. Macromolecular properties and structural 'architecture' Biochem. J. 276 1991 667 675
45. V.P. Torchilin Recent advances with liposomes as pharmaceutical carriers Nat. Rev. Drug Discov. 4 2005 145 160
46. V.L. Truong-Le, S.M. Walsh, E. Schweibert, H.Q. Mao, W.B. Guggino, J.T. August, and K.W. Leong Gene transfer by DNA-gelatin nanospheres Arch. Biochem. Biophys. 361 1999 47 56
47. A. Vila, A. Sanchez, C. Evora, I. Soriano, J.L. Vila Jato, and M.J. Alonso PEG-PLA nanoparticles as carriers for nasal vaccine delivery J. Aerosol Med. 17 2004 174 185
48. R. Weissleder, and U. Mahmood Molecular imaging Radiology 219 2001 316 333
49. C. Wickstrom, J.R. Davies, G.V. Eriksen, E.C. Veerman, and I. Carlstedt MUC5B is a major gel-forming, oligomeric mucin from human salivary gland, respiratory tract and endocervix: identification of glycoforms and C-terminal cleavage Biochem. J. 334 1998 685 693
50. K. Zaret Regenerative medicine - self-help for insulin cells Nature 429 2004 30 31
51. Y. Zhang, B. Doranz, J.R. Yankaskas, and J.F. Engelhardt Genotypic analysis of respiratory mucus sulfation defects in cystic fibrosis J. Clin. Invest. 96 1995 2997 3004